from the 04 January anns:PolyNovo will now pursue negotiations with multi-national wound companies for the US distribution rights with PolyNovo to retain manufacturing of the finished product.
The CEO Paul Brennan said; "This is a significant milestone as FDA approval means we now have access to the largest reimbursed dermal matrix market in the world. We will be negotiating a North American licence agreement with multinationals so that we can get rapid market access. We are now focused on business development and execution of our commercial plans in the US and other markets."
Could be any day now.
from the 04 January anns: PolyNovo will now pursue negotiations...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.51 |
Change
0.160(6.81%) |
Mkt cap ! $1.692B | |||
| Open | High | Low | Value | Volume |
| $2.38 | $2.52 | $2.38 | $2.422M | 984.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 32181 | $2.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.51 | 14383 | 11 |
View Market Depth
| Last trade - 11.35am 10/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |